Pazopanib treatment for primary cardiovascular sarcoma: A retrospective observational study and literature review.

Yamanaka S, Yakushijin Y, Hasebe S, Yamamoto S, Fujii T, Kitazawa R, Fujibuchi T, Kidani T, Maruta M

Open source

DOI
10.3892/ol.2026.15829
Published
2026 Oct
Container
Oncology letters
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/ol.2026.15829,
  title = {Pazopanib treatment for primary cardiovascular sarcoma: A retrospective observational study and literature review.},
  author = {Yamanaka S and Yakushijin Y and Hasebe S and Yamamoto S and Fujii T and Kitazawa R and Fujibuchi T and Kidani T and Maruta M},
  year = {2026},
  journal = {Oncology letters},
  doi = {10.3892/ol.2026.15829},
  url = {https://doi.org/10.3892/ol.2026.15829}
}

RIS

TY  - JOUR
TI  - Pazopanib treatment for primary cardiovascular sarcoma: A retrospective observational study and literature review.
AU  - Yamanaka S
AU  - Yakushijin Y
AU  - Hasebe S
AU  - Yamamoto S
AU  - Fujii T
AU  - Kitazawa R
AU  - Fujibuchi T
AU  - Kidani T
AU  - Maruta M
PY  - 2026
JO  - Oncology letters
DO  - 10.3892/ol.2026.15829
UR  - https://doi.org/10.3892/ol.2026.15829
ER  - 

APA

S, Y., Y, Y., S, H., S, Y., T, F., R, K., T, F., T, K., & M, M. (2026). Pazopanib treatment for primary cardiovascular sarcoma: A retrospective observational study and literature review.. Oncology letters. https://doi.org/10.3892/ol.2026.15829

Source records